IRIS
ARBITRIO, Mariamena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 850
EU - Europa 645
AS - Asia 611
SA - Sud America 127
AF - Africa 33
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 2.277
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 807
IT - Italia 330
SG - Singapore 240
IN - India 101
BR - Brasile 99
DE - Germania 87
GB - Regno Unito 75
CN - Cina 73
FI - Finlandia 36
HK - Hong Kong 33
CA - Canada 28
SE - Svezia 24
PK - Pakistan 23
ID - Indonesia 21
JO - Giordania 21
VN - Vietnam 20
NL - Olanda 19
ES - Italia 12
BD - Bangladesh 11
FR - Francia 10
MX - Messico 10
RU - Federazione Russa 10
ZA - Sudafrica 10
SA - Arabia Saudita 9
EG - Egitto 8
CO - Colombia 7
CZ - Repubblica Ceca 7
LT - Lituania 7
PT - Portogallo 7
TR - Turchia 7
AE - Emirati Arabi Uniti 6
IQ - Iraq 6
JP - Giappone 6
NG - Nigeria 6
PE - Perù 6
AU - Australia 5
EC - Ecuador 5
ET - Etiopia 5
IE - Irlanda 5
IR - Iran 5
LB - Libano 5
CY - Cipro 4
EU - Europa 4
KR - Corea 4
MY - Malesia 4
AR - Argentina 3
BG - Bulgaria 3
PH - Filippine 3
RO - Romania 3
UA - Ucraina 3
CL - Cile 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
LK - Sri Lanka 2
MA - Marocco 2
PL - Polonia 2
PS - Palestinian Territory 2
PY - Paraguay 2
UY - Uruguay 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
CH - Svizzera 1
KE - Kenya 1
NZ - Nuova Zelanda 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 2.277
Salva come PNG Salva come JPEG
Città #
Singapore 163
Chandler 124
Dallas 63
Munich 62
Ashburn 61
Santa Clara 50
Chicago 48
Bengaluru 46
Hefei 45
London 40
Milan 26
Turku 25
Lawrence 24
Princeton 24
Catanzaro 22
Hong Kong 22
Naples 18
Amman 13
Los Angeles 13
Boardman 12
Carbonia 12
Helsinki 11
New York 11
Ottawa 10
Parma 10
San Nicola Manfredi 10
Spezzano della Sila 10
São Paulo 10
The Dalles 10
Wilmington 10
Ho Chi Minh City 9
Rome 9
Delhi 8
Irbid 8
Brooklyn 7
Frankfurt am Main 7
Kaunas 7
Madrid 7
San Francisco 7
Santo Stefano di Rogliano 7
Chennai 6
Cosenza 6
Ercolano 6
Montreal 6
Seattle 6
Stockholm 6
Afragola 5
Atlanta 5
Cardiff 5
Des Moines 5
Lucknow 5
Olomouc 5
Pune 5
Redmond 5
Riyadh 5
Sacramento 5
Addis Ababa 4
Brescia 4
Dhaka 4
Hyderabad 4
Islamabad 4
Jeddah 4
Johannesburg 4
Kuala Lumpur 4
Lahore 4
Nicosia 4
Redwood City 4
Richmond 4
Tokyo 4
Tubarão 4
West Jordan 4
Acquaviva delle Fonti 3
Ajman 3
Ankara 3
Banyumas 3
Berlin 3
Bologna 3
Bristol 3
Castrovillari 3
Catania 3
Charlotte 3
Chía 3
Dubai 3
Faisalabad 3
Florianópolis 3
Grottaglie 3
Lima 3
Melito di Porto Salvo 3
Mileto 3
Noida 3
Norwalk 3
Nuremberg 3
Oxford 3
Palermo 3
Paola 3
Quţūr 3
San Antonio 3
Santo Tirso 3
Seoul 3
Shanghai 3
Totale 1.314
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 398
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 110
miR-22 suppresses DNA ligase III addiction in multiple myeloma 91
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 90
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 75
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 59
DMET-Analyzer: automatic analysis of Affymetrix DMET Data 58
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 54
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 53
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling 53
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 53
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 52
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 52
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 52
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 49
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 48
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 47
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 46
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 46
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 45
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 45
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 44
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 44
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 43
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 41
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 40
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 40
Mmrf-commpass data integration and analysis for identifying prognostic markers 39
Integration of DNA Microarray with Clinical and Genomic Data 39
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 35
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 35
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 34
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 33
Ethical Perspectives on Pharmacogenomic Profiling 31
Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: relevance to Parkinson’s disease 31
null 31
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 31
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity 29
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 29
Development and validation of bioanalytical methods for LNA-i-miR-221 quantification in human plasma and urine by LC-MS/MS 29
Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis 26
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 26
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 25
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity 24
Polymorphisms and Pharmacogenomics of NQO2: The Past and the Future 14
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 14
null 2
Totale 2.385
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.920
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 7 6 6 6 7 8 11 1 0
2021/2022128 2 0 0 22 5 2 10 22 30 17 13 5
2022/2023376 54 28 29 10 42 30 5 28 40 42 47 21
2023/2024469 87 34 42 37 41 70 27 38 10 17 32 34
2024/2025843 74 20 28 42 51 109 51 53 51 22 149 193
2025/2026474 102 147 128 97 0 0 0 0 0 0 0 0
Totale 2.385